SAN DIEGO, July 17, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed on behalf of investors who purchased or otherwise acquired Biohaven Ltd. (NYSE: BHVN) securities between March 24, 2023 and May 14, 2025. Biohaven is a biopharmaceutical company that discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology. The Company is developing, among other product candidates, troriluzole for the treatment of spinocerebellar ataxia (“SCA”), amo ...

In the meantime, going to follow some significant developments today in the ongoing legal fight over the Trump administration's attempt to end birthright citizenship. A federal judge in New Hampshire issued a preliminary injunction today, temporarily blocking President Trump's executive order ending birthright citizenship. The judge also granted classaction status to a lawsuit seeking to protect babies who would be denied birthright citizenship by the administration.Joining me now is NBC News senior Homelan ...

Legal & Policy Developments - A federal judge in New Hampshire issued a nationwide block against President Trump's order to end birthright citizenship [1] - The judge granted class action status to the plaintiff but excluded parents of children whose citizenship is threatened from the protected class [1][8] - The ACLU filed a class action lawsuit following a Supreme Court decision limiting nationwide injunctions [6] - The ruling is expected to protect over 150,000 children born in the US this year, ensuring their constitutional birthright citizenship [7] Immigration Raids & Conditions - Several groups, including the city of Los Angeles, are suing the Trump administration over immigration raids [2] - Individuals are reportedly being racially profiled and swept up in immigration raids, with constitutional rights being violated [16][17] - Detainees are allegedly held in deplorable conditions, with limited access to water and counsel [18][19] - Lawyers have faced force, including tear gas, while trying to protect people's rights [19] Potential Consequences & Concerns - There are concerns about potential chaos and a humanitarian crisis if 28 states start revoking birthright citizenship [11] - The question of what happens to stateless individuals, particularly those who cannot be repatriated, is raised [12] - Concerns are expressed about the dehumanization of people and the potential for the administration to deprive people of their citizenship [14] - Comparisons are being made between ICE force and vigilantes or Gestapo due to perceived impunity [23]

[Music] We are following this breaking news impacting President Trump's immigration policy. In just the last hour here in New Hampshire, a federal judge issued a nationwide block against the president's order to end birthright citizenship. So that judge granted the plaintiff's bid for class action status, but ruled that the protected class does not include the parents of the children whose citizenship would be threatened.Last month, the Supreme Court limited the power of lower courts to issue nationwide inj ...

Democrats in Congress are slamming the Supreme Court's ruling in the birthright citizenship case. Our next guest, Democratic Congressman Jamie Raskin, wrote on X, "Eager to sue Trump's wounded ego, the Supreme Court ended nationwide injunctions. Trump is crowing, but this is this just means we'll take our smashing wins in four district courts and turn them into wins in 94 district courts. People born here are citizens, period." Ranking member on the House Judiciary Committee, Congressman Jamie Rascin joins ...

Core Viewpoint - The Schall Law Firm is investigating Quipt Home Medical Corp. for potential violations of securities laws, particularly concerning misleading statements and failure to disclose important information to investors [1][2]. Group 1: Investigation Details - The investigation centers on whether Quipt issued false or misleading statements, particularly regarding a press release on May 21, 2025, related to an acquisition offer from Forager Capital Management [2]. - Forager Capital Management, a significant shareholder, has requested Quipt to retract its misleading statement about their offer to acquire 100% of Quipt's common shares at a price of $3.10 per share [2]. - Following the news of the investigation and the press release from Forager, Quipt's shares experienced a decline of over 8.5% on the same day [2]. Group 2: Legal Representation - The Schall Law Firm is representing investors globally and specializes in securities class action lawsuits and shareholder rights litigation [3]. - Shareholders who have suffered losses are encouraged to contact the Schall Law Firm for a free discussion of their rights [3].

Core Viewpoint - The Schall Law Firm is investigating Bausch + Lomb Corporation for potential violations of securities laws, focusing on misleading statements and undisclosed information that may have affected investors [1][2]. Financial Performance - Bausch + Lomb reported an adjusted net loss of $54 million for Q1 2025, a significant decline compared to a net income of $24 million in the same period of the previous year [2]. - The company has lowered its full-year growth outlook, attributing part of this change to the recall of its enVista product [2].

Core Viewpoint - West Pharmaceutical Services, Inc. is facing a federal securities class action due to disappointing revenue and earnings forecasts, attributed to operational challenges and customer losses during the Class Period from February 16, 2023, to February 12, 2025 [1][3]. Group 1: Financial Performance and Forecasts - On February 13, 2025, West issued weak revenue and earnings forecasts for 2025, citing challenges including the loss of two major continuous glucose monitoring (CGM) customers transitioning to in-house manufacturing [3]. - The company's share price dropped by approximately 38%, from $322.28 on February 12, 2025, to $199.11 on February 13, 2025, following the announcement [3]. Group 2: Allegations in the Class Action - The complaint alleges that West failed to disclose significant destocking issues in its high-margin HVP portfolio, contrary to claims of strong visibility into customer demand [4]. - It is claimed that the SmartDose device, positioned as a high-margin growth product, was actually dilutive to profit margins due to operational inefficiencies [4]. - The margin pressures faced by West raised concerns about potential costly restructuring activities, including exiting CGM contracts with long-standing customers [4].

Core Viewpoint - The Schall Law Firm is investigating OneStream, Inc. for potential violations of securities laws, focusing on whether the company made false or misleading statements or failed to disclose important information to investors [1]. Group 1 - The investigation is aimed at protecting the rights of investors who may have suffered losses due to the company's actions [1]. - The Schall Law Firm specializes in securities class action lawsuits and shareholder rights litigation, representing investors globally [2].

LOS ANGELES, May 8, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of SelectQuote, Inc. ("SelectQuote" or "the Company") (NYSE: SLQT) for violations of the securities laws.The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to investors. SelectQuote is the subject of a DOJ False Claims Act filed on May 1, 2025. The f ...